INCRELEX

Mecasermin · Ipsen Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for INCRELEX, covering 2011-02-16 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Increlex Treatment of Children With Chronic Liver Disease and Short Stature [NA]